Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C461-C477. doi: 10.1152/ajpcell.00167.2022. Epub 2022 Jun 27.
Neurohormonal signaling and mitochondrial dynamism are seemingly distinct processes that are almost ubiquitous among multicellular organisms. Both of these processes are regulated by GTPases, and disturbances in either can provoke disease. Here, inconspicuous pathophysiological connectivity between neurohormonal signaling and mitochondrial dynamism is reviewed in the context of cardiac and neurological syndromes. For both processes, greater understanding of basic mechanisms has evoked a reversal of conventional pathophysiological concepts. Thus, neurohormonal systems induced in, and previously thought to be critical for, cardiac functioning in heart failure are now pharmaceutically interrupted as modern standard of care. And, mitochondrial abnormalities in neuropathies that were originally attributed to an imbalance between mitochondrial fusion and fission are increasingly recognized as an interruption of axonal mitochondrial transport. The data are presented in a historical context to provide insight into how scientific thought has evolved and to foster an appreciation for how seemingly different areas of investigation can converge. Finally, some theoretical notions are presented to explain how different molecular and functional defects can evoke tissue-specific disease.
神经激素信号和线粒体动态似乎是两种截然不同的过程,但几乎存在于所有多细胞生物中。这两个过程都受 GTP 酶的调节,任何一个过程的紊乱都可能引发疾病。在这里,我们将回顾一下神经激素信号和线粒体动态在心脏和神经系统综合征中的病理生理学联系。对于这两个过程,对基本机制的深入了解引发了对传统病理生理学概念的颠覆。因此,心力衰竭中诱导的神经激素系统,以及之前被认为对心脏功能至关重要的系统,现在已被药物阻断,成为现代治疗标准。此外,最初归因于线粒体融合和裂变之间失衡的神经病变中的线粒体异常,越来越被认为是轴突线粒体运输中断的结果。这些数据是按历史顺序呈现的,旨在深入了解科学思想的发展,并促使人们认识到看似不同的研究领域如何汇聚。最后,提出了一些理论概念,以解释不同的分子和功能缺陷如何引发组织特异性疾病。